Name | Number of supported studies | Average coverage | |
---|---|---|---|
retina horizontal cell | 5 studies | 23% ± 5% |
Insufficient scRNA-seq data for expression of NAA40 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1502.54 | 1443 / 1445 | 100% | 19.84 | 183 / 183 |
breast | 100% | 1806.84 | 459 / 459 | 100% | 21.29 | 1116 / 1118 |
bladder | 100% | 1371.05 | 21 / 21 | 100% | 20.05 | 503 / 504 |
uterus | 100% | 1492.41 | 170 / 170 | 100% | 22.76 | 458 / 459 |
thymus | 100% | 4285.39 | 653 / 653 | 100% | 19.74 | 603 / 605 |
adrenal gland | 100% | 3082.34 | 258 / 258 | 100% | 20.25 | 229 / 230 |
pancreas | 100% | 1427.19 | 328 / 328 | 99% | 17.50 | 177 / 178 |
intestine | 100% | 2123.74 | 966 / 966 | 99% | 15.77 | 524 / 527 |
lung | 100% | 1744.87 | 576 / 578 | 100% | 20.41 | 1151 / 1155 |
prostate | 100% | 2144.24 | 245 / 245 | 99% | 12.03 | 498 / 502 |
stomach | 100% | 1467.01 | 358 / 359 | 99% | 15.62 | 283 / 286 |
ovary | 99% | 1172.45 | 178 / 180 | 100% | 20.58 | 429 / 430 |
kidney | 100% | 2403.99 | 89 / 89 | 98% | 14.47 | 887 / 901 |
brain | 98% | 1926.87 | 2588 / 2642 | 100% | 27.15 | 705 / 705 |
skin | 98% | 1280.62 | 1774 / 1809 | 99% | 17.26 | 465 / 472 |
liver | 95% | 825.19 | 215 / 226 | 68% | 7.18 | 277 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 24.17 | 29 / 29 |
spleen | 100% | 3993.46 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 18.77 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.93 | 1 / 1 |
adipose | 99% | 1170.58 | 1195 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 1163.07 | 1312 / 1335 | 0% | 0 | 0 / 0 |
heart | 96% | 1992.97 | 828 / 861 | 0% | 0 | 0 / 0 |
muscle | 96% | 848.79 | 772 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 91% | 10.74 | 73 / 80 |
peripheral blood | 76% | 1112.74 | 709 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006629 | Biological process | lipid metabolic process |
GO_0006338 | Biological process | chromatin remodeling |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0034451 | Cellular component | centriolar satellite |
GO_0005634 | Cellular component | nucleus |
GO_0010485 | Molecular function | histone H4 acetyltransferase activity |
GO_1990189 | Molecular function | peptide-serine-alpha-N-acetyltransferase activity |
GO_0043998 | Molecular function | histone H2A acetyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | NAA40 |
Protein name | N-alpha-acetyltransferase 40 (EC 2.3.1.257) (N-acetyltransferase 11) (N-alpha-acetyltransferase D) (NatD) (hNatD) (Protein acetyltransferase 1) N-alpha-acetyltransferase 40, NatD catalytic subunit N-alpha-acetyltransferase 40 (EC 2.3.1.257) |
Synonyms | NAT11 PATT1 |
Description | FUNCTION: N-alpha-acetyltransferase that specifically mediates the acetylation of the N-terminal residues of histones H4 and H2A . In contrast to other N-alpha-acetyltransferase, has a very specific selectivity for histones H4 and H2A N-terminus and specifically recognizes the 'Ser-Gly-Arg-Gly sequence' . Acts as a negative regulator of apoptosis . May play a role in hepatic lipid metabolism (By similarity). . |
Accessions | Q86UY6 ENST00000542163.1 [Q86UY6-3] F2YHM7 F5H2C9 ENST00000539656.5 F5GXF6 ENST00000534965.5 F5GY41 ENST00000544138.5 ENST00000377793.9 [Q86UY6-1] |